Select country change
Shopping cart (0 , 0,00 ) Menu Search
Manufactured by BioVendor

Cystatin C Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, HRP-labelled antibody
  • Other names:Post G-globulin, Cystatin-3, Neuroendocrine basic polypeptide, Gamma-trace, Post-gamma-globulin, CST3
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price


RD191009100 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

Sandwich ELISA, HRP-labelled antibody

Applications

Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate, Urine, Cerebrospinal fluid

Sample Requirements

10 µl/well

Storage/Expiration

Store the kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

200–10 000 ng/ml

Limit of Detection

0.25 ng/ml

Intra-assay (Within-Run)

n = 8; CV = 3.4 %

Inter-assay (Run-to-Run)

n = 5; CV = 6.9 %

Spiking Recovery

95.0 %

Dilutation Linearity

97.8 %

Crossreactivity

  • bovine Non-detectable
  • cat Non-detectable
  • dog Non-detectable
  • goat Non-detectable
  • hamster Non-detectable
  • horse Non-detectable
  • mouse Non-detectable
  • pig Non-detectable
  • rabbit Non-detectable
  • rat Non-detectable
  • sheep Non-detectable
  • chicken Not tested
  • human Yes
  • monkey Yes (recommended dilution 1:400)

Note

Summary

Features

  • European Union: for in vitro diagnostic use
  • Rest of the world: for research use only!
  • The total assay time is less than 2 hours
  • The kit measures total cystatin C in serum, plasma (EDTA, citrate, heparin), urine and cerebrospinal fluid
  • Assay format is 96 wells
  • Quality Controls are human serum or human urine native protein based. No animal sera are used
  • Standard is purified native protein based
  • Components of the kit are provided ready to use or concentrated
  • Convenient for automatization

Research topic

Neural tissue markers, Renal disease

Summary

Cysteine proteinase inhibitors, cystatins superfamily, have been identified in animals, plants
and protozoa. All cystatins inactivate lysosomal cysteine proteinases, e.g. cathepsin B, H, K, L
and S as well as some structurally related plant proteinases, such as papain and actinidin.
Human cystatin C is produced at a constant rate by all nucleated body cells and occurs in all
body fluids abundantly. It is a non-glycosilated basic single-chain protein consisting of 120
amino acids with a molecular weight of 13.36 kDa and is characterized by two disulfide bonds
in the carboxy-terminal region. The protein is encoded by the CS73 gene located on the short
arm of chromosome 20.

Biological function of human cystatin C, and its role in various pathological states, has been the
subject of numerous studies. Imbalance between cystatin C and cysteine proteinases is
associated with diseases such as inflammation, renal failure, cancer, Alzheimer disease,
multiple sclerosis and hereditary cystatin C amyloid angiopathy. Its increased level has been
found in patients with autoimune diseases, with colorectal tumors and metastases, patients
with inflammation and in patients on dialysis. Serum cystatin C concentration correlates
negatively with glomerular filtration rate (GFR) as well as or better than creatinine, therefore
was recently proposed as a new, very sensitive, marker of changes in GFR.

On the other hand, low levels of cystatin C come along the breakdown of the elastic laminae
and, subsequently, the atherosclerosis and abdominal aortic aneurysm, as indicate latest
publications. Results make evident association of cystatin C levels with the incidence of
myocardial infarction, coronary death and angina pectoris. Furthermore, cystatin C correlates
with triglycerides, LDL-cholesterol, BMI and age of individuals. Thus, low concentration of
cystatin C presents a risk factor for secondary cardiovascular events.

References to Product

References

  • Adanir T, Aksun M, Cirit M, Alkan Tasli F, Sahin O, Kestelli M, Aydin Kantaroglu T, Koseoglu M, Sencan A, Karahan N. The renal effect of replacement fluids in controlled severe hemorrhagic shock: an experimental study. Ulus Travma Acil Cerrahi Derg. 2009 Sep;15 (5):423-32
  • Albayrak S, Ordu S, Ozhan H, Yazici M, Aydin M, Alemdar R, Kaya A. Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function. Blood Press. 2009 Sep;18 (4):187-91
  • Androulakis E, Papageorgiou N, Lioudaki E, Chatzistamatiou E, Zacharia E, Kallikazaros I, Tousoulis D. Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C. J Clin Hypertens (Greenwich). 2016 Jul 21;
  • Babelova A, Avaniadi D, Jung O, Fork C, Beckmann J, Kosowski J, Weissmann N, Anilkumar N, Shah AM, Schaefer L, Schroder K, Brandes RP. Role of Nox4 in murine models of kidney disease. Free Radic Biol Med. 2012 Aug 15;53 (4):842-53
  • Barrientos LG, Rollin PE. Release of cellular proteases into the acidic extracellular milieu exacerbates Ebola virus-induced cell damage. Virology . Sep 15 (2006)
  • Bayram A,Esmaoglu A, Akin A,Baskol G, Aksu R, Bicer C, Demirtas A, Mutluay R, Boyaci A. The effects of intraoperative infusion of dexmedetomidine on early renal function after percutaneous nephrolithotomy. Acta Anaesthesiologica Scandin. 2011; 55;:539–544
  • Bhattacharyya S, Wang W, Graham LV, Varga J. A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator. Arthritis Res Ther. 2016 Oct 3;18 (1):216
  • Chen X, Chen Y, Wei Q, Ou R, Cao B, Zhao B, Shang HF. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis. BMC Neurol. 2016;16:173
  • Chung MY, Jun DW, Sung SA. Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. Korean J Hepatol. 2010 Sep;16 (3):301-7
  • Domingueti CP, Fuzatto JA, Foscolo RB, Reis JS, Dusse LM, Carvalho MD, Gomes KB, Fernandes AP. Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus. Clin Chim Acta. 2016 May 18;
  • Esezobor CI, Iroha E, Oladipo O, Onifade E, Soriyan OO, Akinsulie AO, Temiye EO, Ezeaka C. Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula. J Int AIDS Soc. 2010;13:17
  • Gashenko EA, Lebedeva VA, Brak IV, Tsykalenko EA, Vinokurova GV, Korolenko TA. Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer. Int J Circumpolar Health. 2013;72
  • Han J, Gao Y, Guo Q, Su D, Yan B, Peng L, Du Y, Li K, Wang G. Cross-sectional study on the relationship between the level of serum cystatin C and blood pressure reverse dipping in hypertensive patients. BMJ Open. 2016;6 (9):e011166
  • Herath TD, Darveau RP, Seneviratne CJ, Wang CY, Wang Y, Jin L. Heterogeneous Porphyromonas gingivalis LPS modulates immuno-inflammatory response, antioxidant defense and cytoskeletal dynamics in human gingival fibroblasts. Sci Rep. 2016;6:29829
  • Hilmi IA, Peng Z, Planinsic RM, Damian D, Dai F, Tyurina YY, Kagan VE, Kellum JA. N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation. Nephrol Dial Transplant. 2010 Feb 22;
  • Hossain MA, Emara M, El Moselhi H, Shoker A. Comparing measures of cystatin C in human sera by three methods. Am J Nephrol. 2009;29 (5):381-91
  • Ibrahim MA, Ahmed YS, El-Shinnawy HA, Abd Al Maseeh IY, Makkeyah YM, Bichari WA. Value of Urinary Cystatin C In Early Detection Of Diabeticnephropathy In Type 2 Diabetes Mellitus. Int. J. Adv. Res. Biol.Sci.. 2015;2 (3):211-23
  • Kobayashi T, Yoshida T, Fujisawa T, Matsumura Y, Ozawa T, Yanai H, Iwasawa A, Kamachi T, Fujiwara K, Kohno M, Tanaka N. A metabolomics-based approach for predicting stages of chronic kidney disease. Biochem Biophys Res Commun. 2014 Mar 7;445 (2):412-6
  • Korolenko TA, Filatova TG, Cherkanova MS, Khalikova TA, Bravve IIu. [Cystatins: cysteine proteases regulation and disturbances in tumors and inflammation]. Biomed Khim. 2008 Mar-Apr;54 (2):210-7
  • Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O'Connor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008 Oct;74 (8):1059-69
  • Kraydaschenko O, Berezin A, Dolinnaya M. Serum Cystatin C and Neutrophil Gelatinase-Associated Lipocalin as Biomarkers of Glomerular and Tubular Kidney Damage in Patients with Chronic Glomerulonephritis and Saved Renal Function. Biological Markers and Guided . 3 (1):147-154
  • Kumar D, Mishra AK,Fatima J, Siddiqu MS, Rehman M. Cystatin C as a surrogate marker for evaluating glomerular filtration rate in acute kidney injury. J. Evolution Med. Dent. Sci.. April 2016;5 (34):1869-1871
  • Lapinski TW, Parfieniuk A, Rogalska-Plonska M, Czajkowska J, Flisiak R. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Liver Int. 2009 Sep;29 (8):1158-61
  • Liu X, Zeng B, Xu J. Alteration of cystatin C in cerebrospinal fluid of patients with sciatica revealed by a proteomical approach. Saudi Med J. 2005 Nov;26 (11):1699-704
  • Liu XD, Zeng BF, Xu JG, Zhu HB, Xia QC. Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation. Proteomics . Feb;6(3):1019-28 (2006)
  • Liu Y, El-Achkar TM, Wu XR. Tamm-Horsfall protein regulates circulating and renal cytokines by affecting glomerular filtration rate and acting as a urinary cytokine trap. J Biol Chem. 2012 May 11;287 (20):16365-78
  • Malamitsi-Puchner A, Briana DD, Kontara L, Boutsikou M, Baka S, Hassiakos D, Marmarinos A, Gourgiotis D. Serum cystatin C in pregnancies with normal and restricted fetal growth. Reprod Sci. 2007 Jan;14 (1):37-42
  • Malyszko J, Przybylowski P, Koc-Zorawska E, Iaina-Levin N, Sadowski J, Mysliwiec M, Malyszko JS. Copeptin in relation to New York Heart Association class in heart transplant recipients and kidney transplant recipients. Transplant Proc. 2010 Dec;42 (10):4259-62
  • Mareš J, Herzig R, Stejskal D, Vavroušková J, Hluštík P, Urbánek K, Vránová H, Zapletalová J, Pidrman V, Kaňovská P. Use of new markers in the diagnostics of neurodegenerative diseases. Scripa Medica (Brno). 79 (1): 59–68, February 2006;
  • Mares J, Kanovsky P, Herzig R, Stejskal D, Vavrouskova J, Hlustik P, Vranova H, Burval S, Zapletalova J, Pidrman V, Obereigneru R, Suchy A, Vesely J, Podivinsky J, Urbanek K. New laboratory markers in diagnosis of alzheimer dementia. Neurol Res. 2009 Dec;31 (10):1056-9
  • Mares J, Kanovsky P, Herzig R, Stejskal D, Vavrouskova J, Hlustik P, Vranova H, Burval S, Zapletalova J, Pidrman V, Obereigneru R, Suchy A, Vesely J, Podivinsky J, Urbanek K. The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases. Neurol Sci. 2009 Feb;30 (1):1-7
  • Medeiros T, do Rosário NF, Gama NA, Mérida LA, Storch AS, Ferraz L, de Fátima Lopes P, da Silva AA, Almeida JR. Metabolic syndrome components and estimated glomerular filtration rate based on creatinine and/or cystatin C in young adults: A gender issue? Diabetes Metab Syndr. 2017 Mar 6. pii: S1871-4021(17)30004-8. doi: 10.1016/j.dsx.2017.03.015
  • Miele G, Seeger H, Marino D, Eberhard R, Heikenwalder M, Stoeck K, Basagni M, Knight R, Green A, Chianini F, Wuthrich RP, Hock C, Zerr I, Aguzzi A. Urinary alpha1-antichymotrypsin: a biomarker of prion infection. PLoS One. 2008;3 (12):e3870
  • Mlodawska E, Tomaszuk-Kazberuk A, Lopatowska P, Waszkiewicz E, Bachorzewska-Gajewska H, Malyszko J, Michniewicz E, Dobrzycki S, Musial W, J,. Matrix Metalloproteinase Neutrophil Gelatinase-Associated Lipocalin Complex Predicts Atrial Fibrillation Recurrence after Electrical Cardioversion in Obese Patients. Cardiorenal Med. 2017;7 (1):11-20
  • MUNILAKSHMI U1, SHASHIDHAR KN1, MUNINARAYANA C, MADHAVI REDDY, LAKSHMAIAH V. EXPEDIENCY OF MARKERS FOR EARLY DETECTION OF ACUTE KIDNEY INJURY SEQUELAE TO TYPE 2 DIABETES MELLITUS. 2016;9 (4):Asian journal of pharmaceutica
  • Musiol K, Sobol-Milejska G, Nowotka L, Torba K, Kniazewska M, Wos H. Renal function in children treated for central nervous system malignancies. Childs Nerv Syst. 2016 Jun 21;
  • Nakae H, Igarashi T, Tajimi K, Noguchi A, Takahashi I, Tsuchida S, Takahashi T, Asanuma Y. A case report of pediatric fulminant hepatitis treated with plasma diafiltration. Ther Apher Dial. 2008 Aug;12 (4):329-32
  • Pasa S, Bayramli G, Atasoy A, Karul A, Ertug S, Ozensoy Toz S. Evaluation of serum cystatin-C in dogs with visceral leishmaniasis. Vet Res Commun. 2009 Jan 13;
  • Pasa S, Kilic N, Atasoy A, Derincegoz OO, Karul A. Serum Cystatin C Concentration as a Marker Acute Renal Dysfunctionin Critically Ill Dogs. J Anim Vet Advances. 2008, 7 (11): 1410-1412;
  • Przybylowski P, Malyszko J, Malyszko JS. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients. Transplant Proc. 2010 Jun;42 (5):1797-802
  • Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci. 2009 Dec;338 (6):478-80
  • Santana-Santos E, Gowdak LH, Gaiotto FA, Puig LB, Hajjar LA, Zeferino SP, Drager LF, Shimizu MH, Bortolotto LA, De Lima JJ. High Dose of N-Acetylcystein Prevents Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Myocardial Revascularization. Ann Thorac Surg. 2014 Mar 20;
  • Shaarawy M, Fathy SA, Mehany NL, Hindy OW. Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure. Clin Chem Lab Med. 2007;45 (11):1498-503
  • Stejskal D, Vavrouskova J, Mares J, Urbanek K. Applications of new laboratory marker assays in neurological diagnoses - A pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub . Dec;149(2):265-6 (2005)
  • Straface E, Matarrese P, Gambardella L, Vona R, Sgadari A, Silveri MC, Malorni W. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett . May 23;579(13):2759-66 (2005)
  • Taleb S, Cancello R, Clement K, Lacasa D. Cathepsin S promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology . Oct;147(10):4950-9 (2006)
  • Taleb S, Cancello R, Poitou C, Rouault C, Sellam P, Levy P, Bouillot JL, Coussieu C, Basdevant A, Guerre-Millo M, Lacasa D, Clement K. Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women. J Clin Endocrinol Metab . Mar;91(3):1042-7 (2006)
  • Taleb S, Lacasa D, Bastard JP, Poitou C, Cancello R, Pelloux V, Viguerie N, Benis A, Zucker JD, Bouillot JL, Coussieu C, Basdevant A, Langin D, Clement K. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J . Sep;19(11):1540-2 (2005)
  • Trenchevska O, Nedelkov D. Targeted quantitative mass spectrometric immunoassay for human protein variants. Proteome Sci. 2011;9 (1):19
  • Tumminello FM, Flandina C, Crescimanno M, Leto G. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications. Biomed Pharmacother. 2008 Feb;62 (2):130-5
  • von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann K, Lutz J, Heemann U, Nawroth PP, Bierhaus A, Humpert PM. Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes. 2009 Sep;58 (9):2093-9
  • Woischnik M, Bauer A, Aboutaam R, Pamir A, Stanzel F, de Blic J, Griese M. Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis. Eur Respir J. 2008 Jun;31 (6):1197-204
  • Yang X, Wang H, Wang Z, Dong M. Alteration and significance of serum cardiac troponin I and cystatin C in preeclampsia. Clin Chim Acta . Dec;374(1-2):168-9 (2006)
  • Yang Y, Liu S, Qin Z, Cui Y, Qin Y, Bai S. Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barre Syndrome by a proteomical approach. Mol Biol Rep. 2009 Apr;36 (4):677-82
  • Yavuz S, Anarat A, Bayazıt AK. Assessment of cystatin C and cystatin C-based GFR formulas in reflux nephropathy. J Pediatr Urol. September 2013;
  • Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res. 2008 Jan 15;14 (2):470-7
References to Summary

References to Cystatin C

  • Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998 May;101 (5):875-81
  • Delanaye P, Cavalier E, Krzesinski JM. Cystatin C, renal function, and cardiovascular risk. Ann Intern Med. 2008 Feb 19;148 (4):323
  • Deng A, Irizarry MC, Nitsch RM, Growdon JH, Rebeck GW. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am J Pathol. 2001 Sep;159 (3):1061-8
  • Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002 Aug;40 (2):221-6
  • Ekiel I, Abrahamson M, Fulton DB, Lindahl P, Storer AC, Levadoux W, Lafrance M, Labelle S, Pomerleau Y, Groleau D, LeSauteur L, Gehring K. NMR structural studies of human cystatin C dimers and monomers. J Mol Biol. 1997 Aug 15;271 (2):266-77
  • Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, Ferrieres J, Juhan-Vague I, Fruchart JC, Ducimetiere P. Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis. 2006 Apr;185 (2):375-80
  • Macisaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, Poon A, Jenkins MA, Ratnaike SI, Power DA, Jerums G. Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia. 2006 Jul;49 (7):1686-9
  • Mojiminiyi OA, Abdella N. Evaluation of cystatin C and beta-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus. J Diabetes Complications. 2003 May-Jun;17 (3):160-8
  • Moran A, Katz R, Smith NL, Fried LF, Sarnak MJ, Seliger SL, Psaty B, Siscovick DS, Gottdiener JS, Shlipak MG. Cystatin C concentration as a predictor of systolic and diastolic heart failure. J Card Fail. 2008 Feb;14 (1):19-26
  • Muntner P, Mann D, Winston J, Bansilal S, Farkouh ME. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. Am J Cardiol. 2008 Jul 1;102 (1):54-7
  • Muntner P, Winston J, Uribarri J, Mann D, Fox CS. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med. 2008 Apr;121 (4):341-8
  • Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci. 2004;41 (5-6):467-550
  • Nakashima I, Fujinoki M, Fujihara K, Kawamura T, Nishimura T, Nakamura M, Itoyama Y. Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis. Ann Neurol. 2007 Aug;62 (2):197-200; discussion 205
  • Ortiz F, Harmoinen A, Paavonen T, Koskinen P, Gronhagen-Riska C, Honkanen E. Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy?. Clin Nephrol. 2008 Jul;70 (1):18-25
  • Parikh NI, Hwang SJ, Yang Q, Larson MG, Guo CY, Robins SJ, Sutherland P, Benjamin EJ, Levy D, Fox CS. Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol. 2008 Nov 1;102 (9):1194-8
  • Perlemoine C, Beauvieux MC, Rigalleau V, Baillet L, Barthes N, Derache P, Gin H. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism. 2003 Oct;52 (10):1258-64
  • Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G. Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care. 2008 May;31 (5):971-3
  • Risch L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant. 1999 Aug;14 (8):1991-6
  • Samouilidou EC, Grapsa E. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis. Ren Fail. 2008;30 (7):711-5
  • Servais A, Giral P, Bernard M, Bruckert E, Deray G, Isnard Bagnis C. Is serum cystatin-C a reliable marker for metaboli
Related Products Documents